Here's what to know about the PCV shot for your little one, including when to get it and what it helps guard against.

Taiwan will expand its free pneumococcal vaccination program to include high-risk individuals aged 19 to 64 starting March 10 ...

As U.S. regulatory uncertainty swirls around the vaccine space and health care in general, Vaxcyte Inc. stands poised for a ...

The pneumococcal conjugate vaccine – codenamed PCV21/GBP410 – has started pivotal trials in the prevention of both paediatric Streptococcus pneumoniae, which remains a major public health ...

Limited or Ligand Pharmaceuticals Incorporated is a better investment based on AAII's A+ Investor grades, which compare both ...

Pneumococcal conjugate vaccines (PCVs) are known to provide protection against vaccine serotype pneumococcal pneumonia; uncertainty exists regarding the optimum PCV dosing schedule. Methods ...

Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The 15-valent conjugate vaccine was at least as effective ... Prior to COVID-19, pneumococcal vaccines were the largest vaccine market worldwide – estimated at around $8 billion – with Prevnar ...

Research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Vaxcyte in a research report issued to clients and investors on Tuesday, February 25th. Leerink Partnrs ...